138 related articles for article (PubMed ID: 24312836)
1. Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors.
Sharifi H; Mohajjel Nayebia A; Farajnia S
Adv Pharm Bull; 2013; 3(1):203-6. PubMed ID: 24312836
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats.
Mahmoudi J; Mohajjel Nayebi A; Reyhani-Rad S; Samini M
Adv Pharm Bull; 2012; 2(2):149-55. PubMed ID: 24312786
[TBL] [Abstract][Full Text] [Related]
3. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.
Mahmoudi J; Nayebi AM; Samini M; Reyhani-Rad S; Babapour V
Pharmacol Rep; 2011; 63(4):908-14. PubMed ID: 22001978
[TBL] [Abstract][Full Text] [Related]
4. Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson's Disease.
Eyhani-Rad S; Mohajjel Nayebi A; Mahmoudi J; Samini M; Babapour V
Iran J Pharm Res; 2012; 11(4):1175-81. PubMed ID: 24250551
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic administration of buspirone on 6-hydroxydopamine-induced catalepsy in rats.
Sharifi H; Mohajjel Nayebia A; Farajnia S
Adv Pharm Bull; 2012; 2(1):127-31. PubMed ID: 24312782
[TBL] [Abstract][Full Text] [Related]
6. 5-HT(1A) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats.
Mahmoudi J; Mohajjel Nayebi A; Samini M; Reyhani-Rad S; Babapour V
Daru; 2011; 19(5):338-43. PubMed ID: 22615679
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats.
Haddadi R; Eyvari Brooshghalan S; Farajniya S; Mohajjel Nayebi A; Sharifi H
Adv Pharm Bull; 2015 Nov; 5(4):463-9. PubMed ID: 26819917
[TBL] [Abstract][Full Text] [Related]
8. Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats.
Nayebi AM; Rad SR; Saberian M; Azimzadeh S; Samini M
Pharmacol Rep; 2010; 62(2):258-64. PubMed ID: 20508280
[TBL] [Abstract][Full Text] [Related]
9. Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
Haddadi R; Poursina M; Zeraati F; Nadi F
Inflammopharmacology; 2018 Oct; 26(5):1305-1316. PubMed ID: 29616453
[TBL] [Abstract][Full Text] [Related]
10. 8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats.
Sharifi H; Mohajjel Nayebi A; Farajnia S
Iran J Basic Med Sci; 2013 Dec; 16(12):1270-5. PubMed ID: 24570834
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
Haddadi R; Mohajjel Nayebi A; Brooshghalan SE
Neurosci Lett; 2013 Oct; 555():106-11. PubMed ID: 24045063
[TBL] [Abstract][Full Text] [Related]
12. Effect of Chronic Administration of Buspirone and Fluoxetine on Inflammatory Cytokines in 6-Hydroxydopamine-lesioned Rats.
Sharifi H; Nayebi AM; Farajnia S; Haddadi R
Drug Res (Stuttg); 2015 Aug; 65(8):393-7. PubMed ID: 24782287
[TBL] [Abstract][Full Text] [Related]
13. Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats.
Sharifi H; Mohajjel Nayebi A; Farajnia S; Haddadi R
Adv Pharm Bull; 2015 Nov; 5(4):491-5. PubMed ID: 26819921
[TBL] [Abstract][Full Text] [Related]
14. Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats.
Kheradmand A; Nayebi AM; Jorjani M; Haddadi R
Iran J Basic Med Sci; 2016 May; 19(5):490-6. PubMed ID: 27403255
[TBL] [Abstract][Full Text] [Related]
15. Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson's Disease; Possible Involvement of Dopaminergic Neurotransmission.
Vajdi-Hokmabad R; Ziaee M; Sadigh-Eteghad S; Sandoghchian Shotorbani S; Mahmoudi J
Adv Pharm Bull; 2017 Sep; 7(3):359-365. PubMed ID: 29071217
[No Abstract] [Full Text] [Related]
16. The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
Srinivasan J; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):629-38. PubMed ID: 15118809
[TBL] [Abstract][Full Text] [Related]
17. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion.
Srinivasan J; Schmidt WJ
Synapse; 2004 Mar; 51(3):213-8. PubMed ID: 14666519
[TBL] [Abstract][Full Text] [Related]
18. Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease.
Sadeghian Z; Eyvari-Brooshghalan S; Sabahi M; Nourouzi N; Haddadi R
Neurosci Lett; 2022 Nov; 790():136884. PubMed ID: 36162540
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement attenuates haloperidol-induced catalepsy in male rats.
Majidi Zolbanin N; Zolali E; Mohajjel Nayebi A
Adv Pharm Bull; 2014; 4(3):237-41. PubMed ID: 24754006
[TBL] [Abstract][Full Text] [Related]
20. Activation and blockade of serotonin
Guo Y; Zhang L; Zhang J; Du CX; Lv SX; Wang T; Wang HS; Xie W; Liu J
Neurol Res; 2019 Jul; 41(7):585-593. PubMed ID: 30929589
[No Abstract] [Full Text] [Related]
[Next] [New Search]